peter schulman

From the Departments of Anesthesiology and Perioperative Medicine (P.M.S., M.J.M.) and Pediatrics (D.A.B.), Oregon Health and Science University, Portland; the Department of Anesthesiology and Critical Care Medicine, Division of Cardiac Anesthesia, University of New Mexico School of Medicine, Albuquerque (N.S.G.); and the Department of Pediatrics, University of Cincinnati, College of Medicine, and the Division of Critical Care Medicine, Cincinnati Children’s Hospital Medical Center,...

The use of a PDNA model for AF ablation is supported by the literature, particularly when moderate sedation is targeted. Nonetheless, GA or deep sedation by an anesthesia provider may be preferred, especially for cases that are prolonged, complex, being performed in the elderly patient, or in those with significant comorbidities.

Background  The use of warfarin in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) can be problematic because of increased bleeding risk. We performed a systematic review and meta-analysis of observational studies that evaluated the use of warfarin in patients with AF and CKD to evaluate the risks of ischemic stroke/thromboembolism, major bleeding, and mortality.